Alessandro Maloberti

3.7k total citations
121 papers, 1.1k citations indexed

About

Alessandro Maloberti is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Nephrology. According to data from OpenAlex, Alessandro Maloberti has authored 121 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Cardiology and Cardiovascular Medicine, 24 papers in Surgery and 20 papers in Nephrology. Recurrent topics in Alessandro Maloberti's work include Cardiovascular Health and Disease Prevention (30 papers), Blood Pressure and Hypertension Studies (25 papers) and Gout, Hyperuricemia, Uric Acid (18 papers). Alessandro Maloberti is often cited by papers focused on Cardiovascular Health and Disease Prevention (30 papers), Blood Pressure and Hypertension Studies (25 papers) and Gout, Hyperuricemia, Uric Acid (18 papers). Alessandro Maloberti collaborates with scholars based in Italy, Spain and United States. Alessandro Maloberti's co-authors include Cristina Giannattasio, Guıdo Grassı, Giuseppe Mancia, Paola Vallerio, Rita Facchetti, Michele Bombelli, Stefano Nava, Marisa Varrenti, Matteo Palazzini and Paola Rebora and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Alessandro Maloberti

104 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Maloberti Italy 19 609 277 177 139 127 121 1.1k
Kenechukwu Mezue United States 13 659 1.1× 264 1.0× 196 1.1× 151 1.1× 236 1.9× 44 1.2k
Sílvio Henrique Barberato Brazil 18 591 1.0× 523 1.9× 191 1.1× 74 0.5× 114 0.9× 49 1.1k
Felix S. Seibert Germany 20 549 0.9× 289 1.0× 212 1.2× 99 0.7× 137 1.1× 78 1.3k
Arturo Carratalá Spain 18 528 0.9× 103 0.4× 232 1.3× 129 0.9× 253 2.0× 56 1.1k
Lucia Barbieri Italy 23 880 1.4× 239 0.9× 502 2.8× 194 1.4× 144 1.1× 114 1.6k
George Gibson United Kingdom 13 552 0.9× 127 0.5× 385 2.2× 216 1.6× 165 1.3× 22 1.2k
Silvio Bertoli Italy 18 433 0.7× 767 2.8× 178 1.0× 78 0.6× 256 2.0× 62 1.4k
Nadia Aspromonte Italy 22 1.0k 1.7× 116 0.4× 312 1.8× 145 1.0× 171 1.3× 129 1.5k
Alessandro Putzu Switzerland 21 423 0.7× 145 0.5× 309 1.7× 243 1.7× 308 2.4× 47 1.2k

Countries citing papers authored by Alessandro Maloberti

Since Specialization
Citations

This map shows the geographic impact of Alessandro Maloberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Maloberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Maloberti more than expected).

Fields of papers citing papers by Alessandro Maloberti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Maloberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Maloberti. The network helps show where Alessandro Maloberti may publish in the future.

Co-authorship network of co-authors of Alessandro Maloberti

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Maloberti. A scholar is included among the top collaborators of Alessandro Maloberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Maloberti. Alessandro Maloberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maloberti, Alessandro, et al.. (2025). Anderson–Fabry Disease: An Overview of Current Diagnosis, Arrhythmic Risk Stratification, and Therapeutic Strategies. Diagnostics. 15(2). 139–139. 2 indexed citations
2.
Favero, Vittoria, Davide Paolo Bernasconi, Alessandro Maloberti, et al.. (2025). Cardiometabolic Risk Parameters in “Nonfunctioning” Adrenal Incidentalomas: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 111(2). e619–e629. 1 indexed citations
3.
Zuin, Marco, Fernándo Domínguez, Alessandro Maloberti, et al.. (2025). Alcoholic cardiomyopathy-attributed mortality in Europe, 2012–20. European Heart Journal - Quality of Care and Clinical Outcomes. 11(7). 1082–1090.
4.
Maloberti, Alessandro, et al.. (2025). Serum Uric Acid in the PAMELA Study: Main Findings and Association with the Atherogenic Index of Plasma. Metabolites. 15(10). 671–671.
5.
Maloberti, Alessandro, Cristina Giannattasio, Marco Zuin, et al.. (2025). The role of inflammation in acute coronary syndrome: A systematic review on biochemical inflammatory assessment and anti-inflammatory therapies. Nutrition Metabolism and Cardiovascular Diseases. 36(2). 104409–104409. 1 indexed citations
6.
Morelli, Martina, et al.. (2025). Pulse Wave Velocity Progression Determinants: No Significant Association with Novel Lipids Parameter. High Blood Pressure & Cardiovascular Prevention. 32(6). 645–655.
8.
Maloberti, Alessandro, et al.. (2024). Cardiac amyloidosis red flags: What all the cardiologist have to know. International Journal of Cardiology Cardiovascular Risk and Prevention. 21. 200271–200271. 6 indexed citations
11.
Giacalone, Annalisa, Michele Bombelli, Chiara Ceresa, et al.. (2024). Neurological hypertensive emergencies: Correlation of blood pressure values with in-hospital outcomes in ischemic stroke. European Journal of Internal Medicine. 124. 61–68.
12.
Ciliberti, Giuseppe, Maurizio Giuseppe Abrignani, Pier Luigi Temporelli, et al.. (2024). Sostanze d’abuso e rischio cardiovascolare: gli energy drinks. Giornale italiano di cardiologia. 25(8). 546–556. 1 indexed citations
13.
Morelli, Martina, et al.. (2024). Hyperuricemia in Cardiac Rehabilitation Patients: Prevalence and Association with Functional Improvement and Left Ventricular Ejection Fraction. High Blood Pressure & Cardiovascular Prevention. 31(5). 461–471. 1 indexed citations
14.
Mancusi, Costantino, Enrica Golia, Arturo Cesaro, et al.. (2024). Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement. Nutrition Metabolism and Cardiovascular Diseases. 35(2). 103712–103712. 1 indexed citations
15.
Abrignani, Maurizio Giuseppe, Edoardo Gronda, Marco Marini, et al.. (2024). Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem. Cardiovascular Drugs and Therapy. 39(4). 857–874. 2 indexed citations
16.
Zuin, Marco, Alberto Corsini, Alessandro Maloberti, et al.. (2024). Role of PCSK9 inhibitors in venous thromboembolism: current evidence and unmet clinical needs. European Heart Journal - Cardiovascular Pharmacotherapy. 10(8). 719–724. 1 indexed citations
17.
Bombelli, Michele, Rita Facchetti, Alessandro Maloberti, et al.. (2023). Impact of the Increase in Left Ventricular Mass on the Risk of Long-Term Cardiovascular Mortality: A Prospective Cohort Study. Hypertension. 80(6). 1321–1330. 14 indexed citations
19.
Greco, Andrea, Agostino Brugnera, Roberta Adorni, et al.. (2021). Protein Intake and Physical Activity in Newly Diagnosed Patients with Acute Coronary Syndrome: A 5-Year Longitudinal Study. Nutrients. 13(2). 634–634. 15 indexed citations
20.
Giannattasio, Cristina, Francesca Cesana, Silvia Maestroni, et al.. (2011). Comparison of Echotracking and Magnetic Resonance Assessment of Abdominal Aorta Distensibility and Relationships with Pulse Wave Velocity. Ultrasound in Medicine & Biology. 37(12). 1970–1976. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026